# Sadayoshi Ito

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sadayoshi-ito/

## Facts

| Field | Value |
| --- | --- |
| Citations | 42,636 |
| Field | Hormonal Regulation and Hypertension |
| h-index | 100 |
| i10-index | 554 |
| OpenAlex ID | https://openalex.org/A5066495888 |
| ORCID iD | https://orcid.org/0000-0002-5092-3626 |
| Works | 1,408 |

## Researcher papers

Showing 12 of 15.

- [The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)](https://scholariq.org/papers/the-japanese-society-of-hypertension-guidelines-for-the-management-of/)
- [Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)](https://scholariq.org/papers/erratum-the-japanese-society-of-hypertension-guidelines-for-the-management-of-2/)
- [Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes](https://scholariq.org/papers/olmesartan-for-the-delay-or-prevention-of-microalbuminuria-in-type-2-diabetes/)
- [Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure](https://scholariq.org/papers/multinational-assessment-of-accuracy-of-equations-for-predicting-risk-of-kidney/)
- [Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease](https://scholariq.org/papers/estimation-of-glomerular-filtration-rate-by-the-mdrd-study-equation-modified-for/)
- [Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2](https://scholariq.org/papers/erratum-the-japanese-society-of-hypertension-guidelines-for-the-management-of/)
- [Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial](https://scholariq.org/papers/febuxostat-therapy-for-patients-with-stage-3-ckd-and-asymptomatic-hyperuricemia/)
- [Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials](https://scholariq.org/papers/change-in-albuminuria-as-a-surrogate-endpoint-for-progression-of-kidney-disease/)
- [Modification of the Modification of Diet in Renal Disease (MDRD) Study Equation for Japan](https://scholariq.org/papers/modification-of-the-modification-of-diet-in-renal-disease-mdrd-study-equation/)
- [Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes](https://scholariq.org/papers/estimated-glomerular-filtration-rate-albuminuria-and-adverse-outcomes/)
- [Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies](https://scholariq.org/papers/change-in-albuminuria-and-subsequent-risk-of-end-stage-kidney-disease-an/)
- [Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease](https://scholariq.org/papers/gut-microbiome-derived-phenyl-sulfate-contributes-to-albuminuria-in-diabetic/)

## Researcher topics

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.